Citation

Robarge KD, Lee W, Eigenbrot C, Ultsch M, Wiesmann C, Heald R, Price S, Hewitt J, Jackson P, Savy P, Burton B, Choo EF, Pang J, Boggs J, Yang A, Yang X, Baumgardner M.: Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479. Bioorg Med Chem Lett, Volume 24 (19), 2014

Authors

Baumgardner M., Boggs J, Burton B, Choo EF, Eigenbrot C, Heald R, Hewitt J, Jackson P, Lee W, Pang J, Price S, Robarge KD, Savy P, Ultsch M, Wiesmann C, Yang A, Yang X

Journal

Bioorg Med Chem Lett

Year

2014

DOI

10.1016/j.bmcl.2014.08.008

PubMed

25193232

Machine-readable

REST APIRDF